BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35594773)

  • 1. The implications of gene mutations in salivary DNA for noninvasive diagnosis of head and neck cancer with a focus on oral cancer.
    Yang X; Song H; Ji T; Du G; Liu W
    Oral Oncol; 2022 Jul; 130():105924. PubMed ID: 35594773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnostic value and prospects of gene mutations in circulating tumor DNA for head and neck cancer monitoring.
    Yang X; Xu X; Zhang C; Ji T; Wan T; Liu W
    Oral Oncol; 2022 May; 128():105846. PubMed ID: 35358785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation detection in saliva from oral cancer patients.
    Ahmed AA; Sborchia M; Bye H; Roman-Escorza M; Amar A; Henley-Smith R; Odell E; McGurk M; Simpson M; Ng T; Sawyer EJ; Mathew CG
    Oral Oncol; 2024 Apr; 151():106717. PubMed ID: 38412584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Proteomic Landscape of Growth Factor Signaling Networks Associated with
    Chen Z; Zhang C; Chen J; Wang D; Tu J; Van Waes C; Saba NF; Chen ZG; Chen Z
    Cancer Res; 2021 Sep; 81(17):4402-4416. PubMed ID: 34167951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating tumour DNA alterations as biomarkers for head and neck cancer: a systematic review.
    Pall AH; Jakobsen KK; Grønhøj C; von Buchwald C
    Acta Oncol; 2020 Jul; 59(7):845-850. PubMed ID: 32223478
    [No Abstract]   [Full Text] [Related]  

  • 6. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
    Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
    PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct pattern of TP53 mutations in human immunodeficiency virus-related head and neck squamous cell carcinoma.
    Gleber-Netto FO; Zhao M; Trivedi S; Wang J; Jasser S; McDowell C; Kadara H; Zhang J; Wang J; William WN; Lee JJ; Nguyen ML; Pai SI; Walline HM; Shin DM; Ferris RL; Carey TE; Myers JN; Pickering CR;
    Cancer; 2018 Jan; 124(1):84-94. PubMed ID: 29053175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Droplet digital PCR for detection and quantification of circulating tumor DNA in plasma of head and neck cancer patients.
    van Ginkel JH; Huibers MMH; van Es RJJ; de Bree R; Willems SM
    BMC Cancer; 2017 Jun; 17(1):428. PubMed ID: 28629339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression levels of miR-34-family microRNAs are associated with TP53 mutation status in head and neck squamous cell carcinoma.
    Metheetrairut C; Chotigavanich C; Amornpichetkul K; Keskool P; Ongard S; Metheetrairut C
    Eur Arch Otorhinolaryngol; 2019 Feb; 276(2):521-533. PubMed ID: 30515607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting therapeutic responses in head and neck squamous cell carcinoma from
    Wei M; Zhi J; Li L; Wang W
    Transl Cancer Res; 2023 Dec; 12(12):3604-3617. PubMed ID: 38197078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of somatic mutations and HPV in the saliva and plasma of patients with head and neck squamous cell carcinomas.
    Wang Y; Springer S; Mulvey CL; Silliman N; Schaefer J; Sausen M; James N; Rettig EM; Guo T; Pickering CR; Bishop JA; Chung CH; Califano JA; Eisele DW; Fakhry C; Gourin CG; Ha PK; Kang H; Kiess A; Koch WM; Myers JN; Quon H; Richmon JD; Sidransky D; Tufano RP; Westra WH; Bettegowda C; Diaz LA; Papadopoulos N; Kinzler KW; Vogelstein B; Agrawal N
    Sci Transl Med; 2015 Jun; 7(293):293ra104. PubMed ID: 26109104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted sequencing reveals TP53 as a potential diagnostic biomarker in the post-treatment surveillance of head and neck cancer.
    van Ginkel JH; de Leng WW; de Bree R; van Es RJ; Willems SM
    Oncotarget; 2016 Sep; 7(38):61575-61586. PubMed ID: 27528217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultrasensitive detection of tumor-specific mutations in saliva of patients with oral cavity squamous cell carcinoma.
    Shanmugam A; Hariharan AK; Hasina R; Nair JR; Katragadda S; Irusappan S; Ravichandran A; Veeramachaneni V; Bettadapura R; Bhati M; Ramaswamy V; Rao VUS; Bagadia RK; Manjunath A; Manjunath NML; Solomon MC; Maji S; Bahadur U; Bettegowda C; Papadopoulos N; Lingen MW; Hariharan R; Gupta V; Agrawal N; Izumchenko E
    Cancer; 2021 May; 127(10):1576-1589. PubMed ID: 33405231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma.
    Lim SM; Cho SH; Hwang IG; Choi JW; Chang H; Ahn MJ; Park KU; Kim JW; Ko YH; Ahn HK; Cho BC; Nam BH; Chun SH; Hong JH; Kwon JH; Choi JG; Kang EJ; Yun T; Lee KW; Kim JH; Kim JS; Lee HW; Kim MK; Jung D; Kim JE; Keam B; Yun HJ; Kim S; Kim HR
    Cancer Res Treat; 2019 Jan; 51(1):300-312. PubMed ID: 29747488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-Invasive Saliva-based Detection of Gene Mutations in Oral Cancer Patients by Oral Rub and Rinse Technique.
    D'Cruz A; Dechamma PN; Saldanha M; Maben S; Shetty P; Chakraborty A
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3287-3291. PubMed ID: 34711005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary oral squamous cell carcinoma associated with CDKN2A germline mutation: a case report.
    Jeong AR; Forbes K; Orosco RK; Cohen EEW
    J Otolaryngol Head Neck Surg; 2022 Feb; 51(1):5. PubMed ID: 35123577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline variants in DNA repair genes are associated with young-onset head and neck cancer.
    Cury SS; Miranda PM; Marchi FA; Canto LMD; Chulam TC; Petersen AH; Aagaard MM; Pinto CAL; Kowalski LP; Rogatto SR
    Oral Oncol; 2021 Nov; 122():105545. PubMed ID: 34598035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of genetic variants of frequently mutated genes in human papillomavirus-negative primary head and neck squamous cell carcinoma, resection margins, local recurrences and corresponding circulating cell-free DNA.
    Flach S; Kumbrink J; Walz C; Hess J; Drexler G; Belka C; Canis M; Jung A; Baumeister P
    J Oral Pathol Med; 2022 Sep; 51(8):738-746. PubMed ID: 35895622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation signature analysis identifies increased mutation caused by tobacco smoke associated DNA adducts in larynx squamous cell carcinoma compared with oral cavity and oropharynx.
    South AP; den Breems NY; Richa T; Nwagu U; Zhan T; Poojan S; Martinez-Outschoorn U; Johnson JM; Luginbuhl AJ; Curry JM
    Sci Rep; 2019 Dec; 9(1):19256. PubMed ID: 31848367
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.